Skip to content

S-Pharma

Active Risk: not assessed Private limited companyfounded 2025active for less than a yearSmiskensstraat 121, 2300 TurnhoutKBO/BCE: BE 1032.114.741

Board

1 director, since incorporation
Director (not named in the articles)
appointed by deed of 29-12-2025 term without a fixed end
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 29-12-2025

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
Board
Mandates as a list
    • Director (not named in the articles), appointed by deed of 29-12-2025, still in office

Control

Founder
This company
S-Pharma

Capital

Contribution
€3,000
Shares
100
Contribution per share
€30
Source
deed of 29-12-2025

Articles of association

deed of 29-12-2025 (in Dutch)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Board ruleThese rules set how the board is made up, meets and takes decisions.
“Die een vertrekvergoeding kan toekennen, De niet-statutaire bestuurders zijn herroepbaar ad nutum bij besluit van de algemene vergadering”
Financial yearThe company draws up its annual accounts over this twelve-month period.
From 1 January to 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“Ieder jaar wordt een gewone algemene vergadering van aandeelhouders gehouden, de dertigste van de maand juni, om 14.00 uur. Valt de…”

Shareholders

At incorporation deed of 29-12-2025 ↗
  • 100 shares (100%) · €3,000

Next steps